Amgen's T-Cell Engager Shows Phase II Promise in Tough to Treat Lung Cancer | BioSpace

Retrieved on: 2023-10-20 21:12:16

Tags for this article:

Click the tags to see associated articles and topics

Amgen's T-Cell Engager Shows Phase II Promise in Tough to Treat Lung Cancer | BioSpace. View article details on hiswai:

Excerpt

Roche Cuts Pipeline as COVID, Currency Headwinds Impact Q3 Results · Royalty Boosts Struggling PTC with Additional $1B for Royalties on Roche's ...

Article found on: www.biospace.com